Mydecine Vends Mindleap for C$4 Million
On Thursday, Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) announced that it had signed an LOI to sell its digital technology subsidiary, Mindleap Health Inc., to PanGenomic Health Inc. The deal is valued.